Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34⁺ cells(legacy) | 151 |
| The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34⁺ cells(legacy) | 91 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34⁺ cells | 1 | 7 | 1 | 4 | 2 | 6 | 3 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 87 |
| China | 16 |
| Vietnam | 12 |
| France | 11 |
| Netherlands | 8 |
| Australia | 6 |
| Canada | 1 |
| Ireland | 1 |
| Iran | 1 |
| Singapore | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 23 |
| Hanoi | 12 |
| Buffalo | 10 |
| Rotterdam | 8 |
| Cambridge | 6 |
| Fairfield | 6 |
| Kaleen | 6 |
| Zhengzhou | 6 |
| New York | 4 |
| Seattle | 3 |